The Departments of Health and Human Services, Labor, and Treasury finalized a rule allowing grandfathered health plans to increase enrollees’ premiums and cost-sharing amounts beyond what is currently allowed.
News
Latest
A recent Centers for Disease Control and Prevention analysis based on 14 states found that the cumulative incidence of lab-confirmed COVID-19 cases among American Indian and Alaska Native persons was 3.5 times higher than among white persons, underscoring the need to develop collaborative approaches with federal, state, municipal and tribal agencies to minimize the impact of COVID-19 on these communities.
The Senate passed by voice vote a continuing resolution that generally extends current federal funding levels for health care and all other programs through Dec. 18, preventing a government shutdown when fiscal year 2020 funding expires tonight.
he AHA expressed support for the bipartisan Dr. Lorna Breen Health Care Provider Protection Act (S. 4349/H.R. 8094), legislation that aims to reduce and prevent burnout, behavioral disorders and suicide among health care professionals.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Dec. 10 recommended the approval of Pfizer, Inc.’s BNT162b2 mRNA COVID-19 vaccine. The panel voted 17-4, with one abstention, that FDA issue an emergency use authorization.
The AHA urged President-elect Biden to implement during his first 100 days in office urgent policy recommendations to ensure America’s hospitals can continue to fight the pandemic, recover and rebuild a better health care system for the future.
Benjamin Franklin said “energy and persistence conquers all things.” Those words are certainly appropriate for this year as we continue our battle against COVID-19. They also are very pertinent for the next week as we must keep the pressure on Congress to make sure they provide hospitals and health systems — and the women and men on the front lines of the COVID-19 fight — with additional support and resources.
The Centers for Medicare & Medicaid Services issued a proposed rule that seeks to streamline prior authorization processes implemented by health plans serving the Medicaid, Children’s Health Insurance Program and federal Health Insurance Marketplace.
More than 3.8 million people selected a 2021 health plan through HealthCare.gov Nov. 1 to Dec. 5, including more than 915,000 last week, the Centers for Medicare & Medicaid Services announced.
The Centers for Disease Control and Prevention announced the expansion of its effort to provide viewable, downloadable county-level data on health-related outcomes and chronic disease prevalence.
The Centers for Medicare & Medicaid Services released a request for applications from Medicare Advantage and prescription drug plans to participate in the Value-Based Insurance Design Model, including its hospice benefit component, in calendar year 2022.
President-elect Joe Biden nominated former White House Chief of Staff Denis McDonough as Secretary of Veterans Affairs. McDonough also previously served the Obama administration as deputy national security advisor.
The Health Resources and Services Administration released its long-awaited final rule implementing an Affordable Care Act requirement that the agency establish a process to resolve disputes between 340B covered entities and drug manufacturers.
The Department of Health and Human Services’ Office for Civil Rights released a proposed rule that would modify HIPAA privacy standards for individually identifiable health information.
With the COVID-19 pandemic affecting some individuals and communities much more than others, population health tools are more important than ever.
The Food and Drug Administration authorized LabCorp’s Pixel COVID-19 Test Home Collection Kit for use by adults without a prescription.
The Centers for Medicare & Medicaid Services updated its FAQs regarding coverage, billing and payment for monoclonal antibody therapies used to treat COVID-19.
The Department of Defense announced a phased plan for the distribution and administration of initial and subsequent COVID-19 vaccine allocations to populations of DoD uniformed service members, including members of the National Guard; dependents; retirees; civilian employees; and select DoD contract personnel as authorized in accordance with agency regulation.
Peer-reviewed data for Pfizer Inc.’s BNT162b2 mRNA COVID-19 vaccine candidate was published by the New England Journal of Medicine, confirming its safety and efficacy.
The Department of Health and Human Services updated its guidance to hospitals on the reporting of COVID-19-related data.